» Authors » S S Poulsen

S S Poulsen

Explore the profile of S S Poulsen including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 154
Citations 1664
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Lundh M, Galbo T, Poulsen S, Mandrup-Poulsen T
Diabetes Obes Metab . 2015 Apr; 17(7):703-7. PMID: 25846481
Failure of pancreatic β cells to compensate for insulin resistance is a prerequisite for the development of type 2 diabetes. Sustained elevated circulating levels of free fatty acids and glucose...
2.
Tougaard P, Skov S, Pedersen A, Krych L, Nielsen D, Bahl M, et al.
Eur J Immunol . 2014 Nov; 45(3):865-75. PMID: 25404161
TL1A is a proinflammatory cytokine, which is prevalent in the gut. High TL1A concentrations are present in patients with inflammatory bowel disease (IBD) and in IBD mouse models. However, the...
3.
Schmidt J, Johansen J, Nielsen M, Zimersson E, Svedman C, Bruze M, et al.
Br J Dermatol . 2013 Oct; 170(2):352-9. PMID: 24124869
Background: Toluene-2,5-diamine (PTD) is the most frequently used dye in oxidative hair dyes on the Scandinavian market. However, little is known about immune responses to PTD-containing oxidative hair dyes. Objectives:...
4.
Pedersen J, Ugleholdt R, Jorgensen S, Windelov J, Grunddal K, Schwartz T, et al.
Am J Physiol Endocrinol Metab . 2012 Nov; 304(1):E60-73. PMID: 23115082
The enteroendocrine K and L cells are responsible for secretion of glucose-dependent insulinotropic polypeptide (GIP) and glucagon like-peptide 1 (GLP-1), whereas pancreatic α-cells are responsible for secretion of glucagon. In...
5.
Lildballe D, Nguyen K, Poulsen S, Nielsen H, Nexo E
Eur J Surg Oncol . 2010 Nov; 37(1):72-9. PMID: 21111562
Aims: No valid markers are routinely available to follow disease progression in patients with fibrolamellar hepatocellular carcinoma (FLHCC). We report data suggesting that the vitamin B12 binding protein haptocorrin (HC)...
6.
Jeppesen P, Lund P, Gottschalck I, Nielsen H, Holst J, Mortensen J, et al.
Gastroenterol Res Pract . 2009 Aug; 2009:616054. PMID: 19707516
Background And Aims: In a short-term study, Glucagon-like peptide 2 (GLP-2) has been shown to improve intestinal absorption in short bowel syndrome (SBS) patients. This study describes longitudinal changes in...
7.
Jeppesen P, Lund P, Gottschalck I, Nielsen H, Holst J, Mortensen J, et al.
Gastroenterol Res Pract . 2009 Jul; 2009:425759. PMID: 19590736
Background And Aims: Glucagon-like peptide 2 (GLP-2) has been shown to improve intestinal absorption in short bowel syndrome (SBS) patients in a short-term study. This study describes safety, compliance, and...
8.
Kjellev S, Nexo E, Thim L, Poulsen S
Br J Pharmacol . 2006 Aug; 149(1):92-9. PMID: 16880764
Background And Purpose: Trefoil factors (TFFs) secreted by mucus-producing cells are essential for the defence of the gastrointestinal mucosa. TFFs probably influence the viscoelastic properties of mucus, but this has...
9.
Ejskjaer K, Sorensen B, Poulsen S, Mogensen O, Forman A, Nexo E
Mol Hum Reprod . 2005 Aug; 11(8):543-51. PMID: 16100239
The epidermal growth factor (EGF) system is ubiquitous in humans and plays fundamental roles in embryogenesis, development, proliferation and differentiation. As the endometrium of fertile women is characterized by proliferation...
10.
Thulesen J, Hartmann B, Hare K, Kissow H, Orskov C, Holst J, et al.
Gut . 2004 Jul; 53(8):1145-50. PMID: 15247183
Background: Glucagon-like peptide 2 (GLP-2) is an intestinotrophic mediator with therapeutic potential in conditions with compromised intestinal capacity. However, growth stimulation of the intestinal system may accelerate the growth of...